{"id":"NCT04123665","sponsor":"GlaxoSmithKline","briefTitle":"A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride","officialTitle":"A Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05-28","primaryCompletion":"2013-12-11","completion":"2013-12-11","firstPosted":"2019-10-11","resultsPosted":"2020-01-31","lastUpdate":"2020-01-31"},"enrollment":98,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Gingivitis"],"interventions":[{"type":"DRUG","name":"Stannous fluoride","otherNames":[]},{"type":"DRUG","name":"Sodium monofluorophosphate","otherNames":["Colgate Cavity ProtectionÂ®, USA marketed dentifrice"]}],"arms":[{"label":"Experimental Test Dentifrice","type":"EXPERIMENTAL"},{"label":"Control Dentifrice","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate and compare the gingival health of a test dentifrice (0.454% weight by weight \\[w/w\\] stannous fluoride) to a negative control dentifrice by comparing modified gingival index, bleeding index and plaque index scores.","primaryOutcome":{"measure":"Evaluation and Comparison of Gingival Health Measured by Bleeding Index (BI) at 24 Weeks","timeFrame":"At Week 24","effectByArm":[{"arm":"Experimental Test Stannous Fluoride Dentifrice","deltaMin":0.11,"sd":0.094},{"arm":"Control Sodium Monofluorophosphate Dentifrice","deltaMin":0.19,"sd":0.105}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["32216778"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["Mouth Ulceration"]}}